Response to influenza vaccine in people with non-protective HI antibody titers

European Journal of Epidemiology

Volumn 21, Issue 11, 2006, Pages 843-845

  Baldo, Vincenzo ^a   Baldovin, Tatjana ^a   Floreani, Annarosa ^a   Minuzzo, Michele ^a   Trivello, Renzo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antibody response; Influenza; MF59; Vaccine

Indexed keywords

FLUAD; INFLUENZA VACCINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; VIRUS VACCINE;

AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CORRELATION ANALYSIS; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INDEPENDENT VARIABLE; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; VIRUS STRAIN;

ADJUVANTS, IMMUNOLOGIC; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; DOUBLE-BLIND METHOD; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION; VACCINES, SUBUNIT;

EID: 33845364182     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-006-9071-4     Document Type: Article

References (8)

1. Vu T, farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002; 20: 1831-1836.
2. De Jong JC , Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, Osterhaus ADME. Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 2003; 115: 63-73.
3. Remarque EJ, De Jong JM , Van Der Klis RJ , Masurel N, Ligthart GJ. Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home patients. Exp Gerontol: 1999; 34: 109-115.
4. Menegon T, Baldo V, Bonello C, Dalla Costa D, Di Tommaso A, Trivello R. Influenza vaccines: antibody responses to split MF59-adjuvanted subunit virus in an adult population. Eur J Epidemiol 1999; 15: 573-576.
5. Beyer WEP, Palache AM, Osterhaus ADME. Comparison of serology and reactogenicity between influenza subunit vaccine and whole virus or split virus: a review and meta-analysis of the literature. Clin Drug Invest 1998; 15: 1-12.
6. Beyer WE, Palache AM, Luchters G, Nauta J, Osterhaus ADME. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res 2004; 103: 125-132.
7. Potter CW. A history of influenza. J Appl Microbiol 2001; 91: 572-579.
8. Nicholson KG, Colegate AE, Podda A, Stephenson I, Wood J, Ypma E, Zambon MC. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet 2001; 357: 1937-1943.